What is the recommended initial management of sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Sepsis

Immediately initiate a structured approach using the NEWS2 score for risk stratification, give crystalloid fluids (30 mL/kg within 3 hours), obtain blood cultures, and administer antibiotics within 1 hour for high-risk patients (NEWS2 ≥7), 3 hours for moderate risk, or 6 hours for low risk, followed by norepinephrine if hypotension persists despite fluid resuscitation. 1

Initial Recognition and Risk Stratification

Use the NEWS2 score to assess risk of severe illness or death from sepsis 1. This is now preferred over qSOFA due to its simplicity and clinical practicality 2. The Sepsis-3 definition requires an increase of ≥2 points in the SOFA score, indicating life-threatening organ dysfunction from dysregulated host response to infection 2.

Risk-based monitoring intervals:

  • High risk (NEWS2 ≥7): Re-evaluate every 30 minutes
  • Moderate risk: Re-evaluate every hour
  • Low risk: Re-evaluate every 4-6 hours 1

Immediate Diagnostic Steps

  • Obtain at least two sets of blood cultures before antibiotics 2, 3
  • Measure lactate early when sepsis is suspected 1, 2
  • Identify anatomic source of infection requiring source control as rapidly as possible 4

Antibiotic Administration (Time-Critical)

The 2024 NICE guidelines moved away from the universal 1-hour target to a risk-stratified approach based on clinical feedback that blanket timing could be harmful and impractical 1:

  • High risk (NEWS2 ≥7): Within 1 hour of initial assessment
  • Moderate risk: Within 3 hours
  • Low risk: Within 6 hours 1

In septic shock specifically, antibiotics must be given within 1 hour; in sepsis without shock, within 3 hours 2. These are maximum timeframes, not targets—use clinical judgment for individual patient needs 1.

Common pitfall: The timeframes represent maximum allowable delays to reduce antibiotic-related harm and promote antimicrobial stewardship, not goals to delay treatment 1.

Fluid Resuscitation

Administer 30 mL/kg of balanced crystalloids within the first 3 hours for initial hemodynamic stabilization 2, 3.

  • Crystalloids are first-choice fluids (strong recommendation, moderate quality evidence) 4
  • Either balanced crystalloids or saline can be used (weak recommendation) 4
  • Albumin may be added when patients require substantial amounts of crystalloids (weak recommendation) 4
  • Never use hydroxyethyl starches (strong recommendation against, high quality evidence) 4
  • Continue fluid challenge technique as long as hemodynamic factors improve 4

After initial resuscitation, guide further fluids by dynamic criteria rather than static volumes 5.

Vasopressor Therapy

If hypotension persists despite adequate fluid resuscitation:

  • Norepinephrine is the first-choice vasopressor (strong recommendation, moderate quality evidence) 4, 3, 6
  • Target mean arterial pressure (MAP) of ≥65 mmHg 4
  • Add vasopressin (up to 0.03 U/min) if additional agent needed to raise MAP or decrease norepinephrine dose (weak recommendation, moderate quality evidence) 4
  • Epinephrine can be added as alternative second agent (weak recommendation, low quality evidence) 4

The guidelines increasingly emphasize early use of vasopressors to prevent hypervolemia 6.

Source Control

  • Identify and implement source control intervention as soon as medically and logistically practical after diagnosis 4
  • Use the intervention with least physiologic insult (e.g., percutaneous drainage over surgical) 4
  • Promptly remove intravascular access devices that are possible sources after establishing alternative access 4

Adjunctive Therapies

Corticosteroids: Consider hydrocortisone (200 mg/day) in shock refractory to vasopressor therapy, especially in septic shock and pneumonia 6, 5. This is increasingly emphasized in recent guidelines 6.

Not recommended as standard therapy: Immunoglobulins, blood purification, metabolic resuscitation cocktails (hydrocortisone + thiamine + vitamin C) lack supporting evidence 5.

Septic Shock Definition

Septic shock is diagnosed when there is:

  • Persistent hypotension despite adequate fluid resuscitation
  • Lactate >2 mmol/L
  • Need for vasopressors to maintain MAP ≥65 mmHg 2

Goal of resuscitation: Achieve lactate clearance 5.

Quality Assurance and Follow-Up

Since 2026, nationwide quality assurance procedures track screening rates, antibiotic timing, standardized treatment, and staff training 2. Survivors require:

  • Early information about potential long-term sequelae including post-intensive care syndrome (PICS)
  • Coordinated discharge planning
  • Structured post-sepsis follow-up care 2, 6

Critical nuance: The shift from universal 1-hour antibiotic targets to risk-stratified timing represents a major evolution in sepsis management, balancing the urgency of treatment against antimicrobial stewardship and potential harm from inappropriate antibiotics 1. However, this applies to suspected sepsis—confirmed septic shock still demands 1-hour antibiotic administration 2.

References

Research

[Sepsis: Update 2026].

Pneumologie (Stuttgart, Germany), 2026

Research

[Sepsis 2026: diagnosis and treatment].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2026

Research

[Therapy of sepsis].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2023

Research

[What is confirmed in the treatment of sepsis? : An update].

Innere Medizin (Heidelberg, Germany), 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.